All recall categories

Prescription and over-the-counter medication recalls

Drug recalls come from the FDA's drug enforcement reports. They range from a wrong label to a product that could be harmful, and the risk level on each notice is the FDA's own classification. Never stop a prescribed medication on the strength of a recall notice alone — the notice will say whether to return it, and your prescriber or pharmacist decides what replaces it.

4,474 stored notices, reported between Jun 20, 2012 and Sep 9, 2026. Newest first.

Drugs

Reported Aug 14, 2013

Excedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-ct tablets in pouches…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Novartis Consumer Health

3 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2013

Reumofan Plus, 30-count tablets per bottle, distriubted by Reumofan Plus USA, LLC and Reumofan USA, LLC, Springfield,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Reumofan Plus USA

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2013

Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Sandoz Incorporated

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2013

Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Sanofi US

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2013

Terazosin Hydrochloride Capsules,10 mg, 100-count bottle, Rx only, Manufactured for Teva Pharmaceuticals USA,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Teva Pharmaceuticals USA, Inc.

3 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2013

VersaPharm Incorporated, Ethambutol Hydrochloride Tablets, USP 400 mg 60 tablets, Rx Only, Mfd. for VersaPharm…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

West-Ward Pharmaceutical Corp.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Aug 14, 2013

Warfarin Sodium Tablets, USP 2 mg, Rx Only, 1000 Tablets per bottle, Manufactured by: Cadila Healthcare Ltd Ahmedabad,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Zydus Pharmaceuticals USA Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

Ranitidine Syrup (Ranitidine Oral Solution USP) 15 mg/mL, Rx Only. Manufactured by VistaPharm, Inc., Birmingham, AL…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Actavis South Atlantic LLC

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose, 5000 mL container, Rx only, Baxter…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Baxter Healthcare Corp.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

Night Bullet Capsules, supplied in 1 count packets, produced by Green Planet Inc, Riverside, CA

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Green Planet Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

Belladonna Alkaloids/PB (Belladonna Alkaloids / Phenobarbital) Tablets Phenobarbital USP 16.2 mg, Hyoscyamine Sulfate…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Physicians Total Care, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

DayQuil Sinex DayTime Sinus Relief (acetaminophen 325 mg and phenylephrine HCl 5 mg) liquicaps and NyQuil Sinex…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Procter & Gamble Co.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

Olanzapine Tablets, USP, 10 mg, Rx Only, 30 tablets per bottle, Mfd for: Prasco Laboratories, Mason OH, 45040, USA, Mfd…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Torrent Pharma Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Aug 7, 2013

Enablex (darifenacin) Extended Release Tablet, 15 mg per tablet. Physician Sample 7 Tablets bottle, Rx only, Mfd by:…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Warner Chilcott US LLC

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

VIVITROL (naltrexone for extended-release injectable suspension) a) 380 mg vial NDC 65757-303-02, b) 380 mg vial in kit…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Alkermes, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

AmBisome (amphotericin B) liposome for injection, 50mg vial, single use vial, For Intravenous Infusion Only, Rx Only,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Astellas Pharma US Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

AmBisome (amphotericin B) liposome for Injection, 50 mg, For Intravenous Infusion Only, Single-Use Vial, Rx Only,…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Gilead Sciences, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

Sodium Chloride Injection, USP, 0.9%, 20 mL Single-dose Fliptop Plastic Vial, packaged in 25 vial Units per carton, Rx…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Hospira Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

LA MER the spf 18 fluid tint , broad spectrum spf 18, 1.7 fl.oz. liq./50 ml, Shade LIGHT 02, UPC 7 47930 00481 3, MAX…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Max Huber Research Labs, Inc.

2 more products in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

Magnesium Sulfate 2 grams in Dextrose 5% for Injection, in 50 mL Plastic Infusion Bags, Med Prep Consulting Inc.,…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Med Prep Consulting, Inc.

1 more product in this recall

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDC…

High riskUsing this product could cause serious injury, illness or death — stop using it now.

Mobius Therapeutics LLC

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

Oxygen, Compressed USP UN1072 Medical Gas supplied in a) 682 litres and b)165 litres cylinders, Rx only, Oklahoma…

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

Oklahoma Respiratory Care Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Pharmalucence, Inc.

FDA (openFDA drug enforcement)

Drugs

Reported Jul 31, 2013

ALCOHOL FREE ANTISEPTIC (cetylpyridinium chloride) Mouth Rinse, 0.07%, mint, 33.8 FL OZ (1 L) bottle, Distributed By…

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

Vi-Jon, Inc.

FDA (openFDA drug enforcement)

Free recall alerts

Get alerted about new Medication recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Related categories

RecallNow is not a government agency. Every notice above was published by the FDA, USDA FSIS or CPSC and links back to its source. Browse the whole archive.